Skye Bioscience, Inc Common Stock
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -9,618 | -3,541 | -7,421 | -4,553 |
EBIT | -9,793 | -3,607 | -7,451 | -4,580 |
Net Income | -9,746 | -3,898 | -7,902 | -5,019 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -8,223 | -6,781 | -7,125 | -4,711 |
Cash | 68,415 | 67,412 | 74,120 | 83,342 |
Basic Shares | 39,968 | 38,819 | 38,669 | 27,999 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -124 | -114 | -34 | |
EBITDA | -13,547 | -12,092 | -7,813 | |
EBIT | -13,671 | -12,207 | -7,847 | |
Net Income | -26,567 | -37,644 | -19,481 | -8,522 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -26,841 | -13,964 | -12,772 | -6,565 |
Cash | 68,415 | 1,256 | 1,244 | 8,983 |
Basic Shares | 36,486 | 7,006 | 493,654 | 1,653 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.29 |
2024-09-30 | -$0.10 |
2024-06-30 | -$0.20 |
2024-03-31 | -$0.18 |
